BML, Inc.

{
  "main_header": {
    "sid": 1129474,
    "name": "BML, Inc.",
    "stock_name": "BML, Inc.",
    "full_name": "BML, Inc.",
    "name_url": "stocks-analysis/bml-inc",
    "exchange": 1,
    "exchangecode": "TKS",
    "country_id": 23,
    "currency": "JPY",
    "cmp": "4,045.00",
    "chg": 760,
    "chgp": "23.14%",
    "dir": 1,
    "prev_price": "3,285.00",
    "mcapval": "157,904.03",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "Japan Nikkei 225",
    "isin": "JP3799700004",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "219.4 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bml-inc-1129474-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "BML, Inc. Adjusts Valuation Amidst Financial Landscape Challenges and Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bml-inc-stock-downgraded-from-buy-to-hold-amid-valuation-decline-3690100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BMLInc_mojoScore_3690100.png",
        "date": "2025-11-11 16:54:20",
        "description": "BML, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment. This change highlights the company's valuation metrics, including its P/E ratio, Price to Book Value, and operational efficiency indicators, reflecting its financial health and market position amidst recent performance challenges."
      }
    ],
    "total": 2,
    "sid": "1129474",
    "stock_news_url": "https://www.marketsmojo.com/news/bml-inc-1129474"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

BML, Inc. Adjusts Valuation Amidst Financial Landscape Challenges and Performance Metrics

2025-11-11 16:54:20

BML, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment. This change highlights the company's valuation metrics, including its P/E ratio, Price to Book Value, and operational efficiency indicators, reflecting its financial health and market position amidst recent performance challenges.

Read full news article

View All News